Mid Atlantic Financial Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,350
Closed -$723K 969
2021
Q2
$723K Sell
4,350
-1,118
-20% -$181K 0.05% 352
2021
Q1
$994K Buy
5,468
+13
+0.2% +$3.02K 0.07% 242
2020
Q4
$1.09M Buy
5,455
+660
+14% +$134K 0.08% 213
2020
Q3
$853K Buy
4,795
+2,573
+116% +$545K 0.07% 241
2020
Q2
$424K Buy
2,222
+216
+11% +$37.9K 0.04% 383
2020
Q1
$311K Buy
+2,006
New +$233K 0.04% 429

Other funds holding TDOC

Mid Atlantic Financial Management's TDOC Position: Q3 2021 in Review

Mid Atlantic Financial Management sold out of Teladoc Health (TDOC) in Q3 2021, closing a stake of 4,350 shares — an estimated $723K sold.

Mid Atlantic Financial Management first reported a position in TDOC in Q1 2020 and held it in 6 quarters. The position peaked at $1.09M in Q4 2020. 761 funds tracked by Wall St. Rank hold TDOC as of Q3 2021.

  • Mid Atlantic Financial Management reported no remaining Teladoc Health position as of Q3 2021 after selling out during the quarter.
  • Mid Atlantic Financial Management sold 4,350 Teladoc Health shares in Q3 2021, an estimated $723K.
  • Mid Atlantic Financial Management first reported a position in Teladoc Health in Q1 2020 and held it in 6 quarters.
  • Mid Atlantic Financial Management's Teladoc Health position peaked at $1.09M in Q4 2020.
  • 761 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.